Administration of pentoxifylline to improve anemia of hemodialysis patients

Introduction: One of the most important causes of erythropoietin-resistant anemia in end-stage renal disease (ESRD) patients is increased levels of inflammatory cytokines. Objectives: In this study pentoxifylline, an anti-inflammatory and anti-cytokine drug, with no significant side effects was used...

Descripción completa

Detalles Bibliográficos
Autores principales: Shahbazian, Heshmatolah, Ghorbani, Ali, Zafar-Mohtashami, Azita, Balali, Abdolreza, AleAli, Armaghan, Lashkarara, Gholam Reza
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nickan Research Institute 2016
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5414521/
https://www.ncbi.nlm.nih.gov/pubmed/28487874
http://dx.doi.org/10.15171/jrip.2017.11

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5414521/
https://www.ncbi.nlm.nih.gov/pubmed/28487874
http://dx.doi.org/10.15171/jrip.2017.11

Ejemplares similares